Instil Bio Inc TIL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
11.30quote price arrow up+0.08 (+0.71%)
Volume
12,312
52 week range
6.07 - 14.00
Loading...
  • Open11.33
  • Day High11.73
  • Day Low10.77
  • Prev Close11.22
  • 52 Week High14.00
  • 52 Week High Date05/09/23
  • 52 Week Low6.07
  • 52 Week Low Date12/07/23

Key Stats

  • Market Cap73.494M
  • Shares Out6.50M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.1
  • YTD % Change48.29

KEY STATS

  • Open11.33
  • Day High11.73
  • Day Low10.77
  • Prev Close11.22
  • 52 Week High14.00
  • 52 Week High Date05/09/23
  • 52 Week Low6.07
  • 52 Week Low Date12/07/23
  • Market Cap73.494M
  • Shares Out6.50M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.1
  • YTD % Change48.29

RATIOS/PROFITABILITY

  • EPS (TTM)-24.00
  • P/E (TTM)-0.47
  • Fwd P/E (NTM)-1.23
  • EBITDA (TTM)-82.354M
  • ROE (TTM)-52.96%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)36.06%

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Instil Bio Inc

 

Profile

MORE
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen...
Bronson Crouch
Chairman of the Board, Chief Executive Officer
Sandeep Laumas M.D.
Chief Financial Officer, Chief Business Officer
Address
3963 Maple Avenue, Suite 350
Dallas, TX
75219
United States

Top Peers

SYMBOLLASTCHG%CHG
INAB
IN8BIO, Inc.
1.00-0.02-1.96%
QNCX
Quince Therapeutics Inc
0.9851+0.0251+2.6146%
IMRX
Immuneering Corp
1.64+0.08+5.13%
TCRT
Alaunos Therapeutics Inc
1.30-0.06-4.41%
CLNN
Clene Inc.
0.4349-0.0018-0.4122%